<code id='348BFF92A3'></code><style id='348BFF92A3'></style>
    • <acronym id='348BFF92A3'></acronym>
      <center id='348BFF92A3'><center id='348BFF92A3'><tfoot id='348BFF92A3'></tfoot></center><abbr id='348BFF92A3'><dir id='348BFF92A3'><tfoot id='348BFF92A3'></tfoot><noframes id='348BFF92A3'>

    • <optgroup id='348BFF92A3'><strike id='348BFF92A3'><sup id='348BFF92A3'></sup></strike><code id='348BFF92A3'></code></optgroup>
        1. <b id='348BFF92A3'><label id='348BFF92A3'><select id='348BFF92A3'><dt id='348BFF92A3'><span id='348BFF92A3'></span></dt></select></label></b><u id='348BFF92A3'></u>
          <i id='348BFF92A3'><strike id='348BFF92A3'><tt id='348BFF92A3'><pre id='348BFF92A3'></pre></tt></strike></i>

          focus

          focus

          author:comprehensive    Page View:844
          Judge's gavel
          Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

          WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

          Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

          advertisement

          Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Why 40% Americans with Parkinson’s don’t see a neurologist
          Why 40% Americans with Parkinson’s don’t see a neurologist

          RichardHuckabee,seenwithhiswife,Angela,saysittooknineyearstobediagnosedwithParkinson’s.CourtesyRicha

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          Do more moles mean more problems? Not so, says new study

          Thenumberofmolesisnotagoodindicatorofcancer'saggressiveness.APStockDermatologistsconstantlyhammerhom